Daniel J. Müller

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey et al. · The Lancet Oncology · 2020 · 600 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process

Kelly E. Caudle, Teri E. Klein, James M. Hoffman et al. · Current Drug Metabolism · 2014 · 436 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i>, <i>CYP2C19</i>, <i>CYP2B6</i>, <i>SLC6A4</i>, and <i>HTR2A</i> Genotypes and Serotonin Reuptake Inhibitor Antidepressants

Chad Bousman, James M. Stevenson, Laura B. Ramsey et al. · Clinical Pharmacology & Therapeutics · 2023 · 403 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2D6</i>, <i>OPRM1</i>, and <i>COMT</i> Genotypes and Select Opioid Therapy

Kristine R. Crews, Andrew A. Monte, Rachel Huddart et al. · Clinical Pharmacology & Therapeutics · 2021 · 399 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

Raymond W. Lam, Sidney H. Kennedy, G. Camelia Adams et al. · The Canadian Journal of Psychiatry · 2024 · 303 citations · Full text

Nursing, Pharmacotherapy, Psychiatry +17